| Teva Pharma AG - Pomalidomid-Teva Mepha 2 mg, Hartkapseln | | 69497 | | 02 | | Pomalidomid-Teva Mepha 2 mg | | Hartkapseln | | L04AX06 | | Pomalidomide | | 11.10.2024 | | |
| | Composition | | pomalidomidum 2 mg, isomaltum 50.2 mg, amylum pregelificatum, natrii stearylis fumaras, Kapselhülle: gelatina, aqua purificata, E 172 (rubrum), E 171, E 172 (flavum), Drucktinte: lacca, ammoniae solutio concentrata, kalii hydroxidum, E 172 (nigrum), pro capsula corresp. natrium 0.04 mg. | | Packungsbestandteile | | Capsules | | | | | | | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | | | | | | | | | | | | | Aqua Purificata | | | | | | color. | | | | color. | | Gelatina | | Kapselhülle | | | 50.2 mg | | | | | | | | | Drucktinte | | | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 14 | PR | PR | A | | Yes | | 004 | 21 | PR | PR | A | | Yes |
|
|
